Advances in Clinical Chemistry
- 1st Edition, Volume 122 - August 6, 2024
- Imprint: Academic Press
- Editor: Gregory S. Makowski
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 7 0 4 - 5
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 7 0 5 - 2
Advances in Clinical Chemistry, Volume 122, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scient… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteAdvances in Clinical Chemistry, Volume 122, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians, and research scientists.
- Provides the most up-to-date technologies in clinical chemistry and clinical laboratory science
- Authored by world renowned clinical laboratory scientists, physicians, and research scientists
- Presents the international benchmark for novel analytical approaches in the clinical laboratory
Clinical Laboratory Professionals, Physicians and Research Scientists
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Preface
- Chapter One: Glycosaminoglycans in mucopolysaccharidoses and other disorders
- Abstract
- 1 Introduction
- 2 Glycosaminoglycans (GAGs)
- 3 GAGs in MPS and other disorders
- 4 Conclusions
- Acknowledgments
- References
- Chapter Two: Volatile organic compounds in cancer and exhaled breath detection technology
- Abstract
- 1 Introduction
- 2 Breath metabolomics
- 3 Gas biomarkers of cancers
- 4 Breath detection technology for cancer
- 5 Problems and challenges in cancer breath detection
- 6 Summary and perspectives
- Acknowledgements
- References
- Chapter Three: Cardiac natriuretic peptides
- Abstract
- 1 Introduction
- 2 History of natriuretic peptides (NPs)
- 3 From gene to bioactive peptide
- 4 Natriuretic peptide (NP) measurement
- 5 Natriuretic peptide (NP) receptors (NPR)
- 6 Physiology that affects clinical measurement
- 7 Natriuretic peptides (NPs) and race
- 8 Natriuretic peptides (NPs) and sex
- 9 Heart failure with reduced ejection fraction
- 10 Heart failure with preserved ejection fraction (HFpEF)
- 11 Other cardiac diseases
- 12 Renal disease
- 13 Conclusions and perspectives
- References
- Chapter Four: Long non-coding and circular RNAs in osteoporosis: Translation to clinical practice
- Abstract
- 1 Introduction
- 2 Overview of non-coding RNA (ncRNA)
- 3 ncRNAs in osteoporosis
- 4 Circulating lncRNA and circRNAs as OP biomarkers
- 5 Pre-analytical considerations in circulating ncRNA analysis
- 6 Conclusions
- References
- Chapter Five: Sputum proteomics in lung disorders
- Abstract
- 1 Introduction
- 2 Lung diseases and their main causes
- 3 Clinical significance of sputum analysis
- 4 Proteomics
- 5 Sputum proteomics in lung disease
- 6 Sputum in lung disease diagnosis and treatment
- 7 Conclusion
- Acknowledgments
- References
- Chapter Six: PTSD biomarkers: Neuroendocrine signaling to epigenetic variants
- Abstract
- 1 Introduction
- 2 The current state of biomarkers in PTSD
- 3 Biomarkers as predictors of treatment outcomes
- 4 Biomarkers and a staged approach to PTSD
- 5 Conclusions and future considerations
- Acknowledgments
- References
- Index
- Edition: 1
- Volume: 122
- Published: August 6, 2024
- No. of pages (Hardback): 282
- No. of pages (eBook): 232
- Imprint: Academic Press
- Language: English
- Hardback ISBN: 9780443297045
- eBook ISBN: 9780443297052
GM
Gregory S. Makowski
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.
Affiliations and expertise
Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USARead Advances in Clinical Chemistry on ScienceDirect